Iron-siRNA Nanohybrids for Enhanced Chemodynamic Therapy via Ferritin Heavy Chain Downregulation
- PMID: 36959091
- DOI: 10.1002/anie.202302255
Iron-siRNA Nanohybrids for Enhanced Chemodynamic Therapy via Ferritin Heavy Chain Downregulation
Abstract
Ferrous iron (Fe2+ ) has more potent hydroxyl radical (⋅OH)-generating ability than other Fenton-type metal ions, making Fe-based nanomaterials attractive for chemodynamic therapy (CDT). However, because Fe2+ can be converted by ferritin heavy chain (FHC) to nontoxic ferric form and then sequestered in ferritin, therapeutic outcomes of Fe-mediated CDT agents are still far from satisfactory. Here we report the synthesis of siRNA-embedded Fe0 nanoparticles (Fe0 -siRNA NPs) for self-reinforcing CDT via FHC downregulation. Upon internalization by cancer cells, pH-responsive Fe0 -siRNA NPs are degraded to release Fe2+ and FHC siRNA in acidic endo/lysosomes with the aid of oxygen (O2 ). The accompanied O2 depletion causes an intracellular pH decrease, which further promotes the degradation of Fe0 -siRNA NPs. In addition to initiating chemodynamic process, Fe2+ -catalyzed ⋅OH generation facilitates endo/lysosomal escape of siRNA by disrupting the membranes, enabling FHC downregulation-enhanced CDT.
Keywords: Chemodynamic Therapy; Fenton Reaction; Ferritin Heavy Chain; Iron Nanoparticles; Small Interfering RNA.
© 2023 Wiley-VCH GmbH.
References
-
- None
-
- Z. Tang, Y. Liu, M. He, W. Bu, Angew. Chem. Int. Ed. 2019, 58, 946-956;
-
- C. Fang, Z. Deng, G. Cao, Q. Chu, Y. Wu, X. Li, X. Peng, G. Han, Adv. Funct. Mater. 2020, 30, 1910085;
-
- K. Yang, G. Yu, Z. Yang, L. Yue, X. Zhang, C. Sun, J. Wei, L. Rao, X. Chen, R. Wang, Angew. Chem. Int. Ed. 2021, 60, 17570-17578;
-
- Y. Zhu, W. Wang, P. Gong, Y. Zhao, Y. Pan, J. Zou, R. Ao, J. Wang, H. Cai, H. Huang, M. Yu, H. Wang, L. Lin, X. Chen, Y. Wu, ACS Nano 2023, 17, 3064-3076;
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
